Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside in the stock price [8]. Core Insights - The company achieved a revenue of RMB 1.95 billion in 2025, representing a year-over-year growth of 18.7%. The net profit attributable to the parent company was RMB 270 million, with a year-over-year increase of 9.5% [9]. - In Q4 2025, the company reported a revenue of RMB 600 million, a year-over-year increase of 23.4%, and a net profit of RMB 40 million, reflecting a year-over-year growth of 26.5% [10]. - The company is focusing on the humanoid robot components business, aiming to leverage its product matrix and partnerships to capture growth in this emerging market [10]. Company Overview - The company operates in the electrical equipment industry, with a current A-share price of RMB 85.52 and a market capitalization of RMB 18.303 billion [2]. - The major shareholder is Nantong Weichuang Electric Technology Co., Ltd., holding 54.12% of the shares [2]. - The company's product mix includes 64.1% from variable frequency drives, 30.3% from servo systems and control systems, and 3.2% from digital energy [4]. Financial Performance - The company forecasts net profits of RMB 270 million, RMB 340 million, and RMB 400 million for 2025, 2026, and 2027, respectively, with year-over-year growth rates of 10%, 27%, and 18% [10]. - The earnings per share (EPS) are projected to be RMB 1.3, RMB 1.6, and RMB 1.9 for the years 2025, 2026, and 2027, respectively [10]. - The price-to-earnings (P/E) ratios for the upcoming years are estimated at 68, 54, and 45 [10]. Market Context - The automation market in China is projected to be around RMB 280 billion in 2025, showing a slight decline of 1% year-over-year, indicating a challenging market environment [10]. - Despite the overall market weakness, the company has managed to grow its revenue significantly, showcasing its resilience and strategic positioning in the industry [10].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a potential upside in the stock price [5][6]. Core Insights - The company achieved a revenue growth of 40% in 2025, marking its first year of profitability, with commercial success becoming evident [6][8]. - The primary revenue driver is the self-developed product, Zebutinib, which generated global sales of $28.1 billion, reflecting a year-over-year increase of 48.8% [8]. - The company provided guidance for 2026, expecting revenue between RMB 43.6 billion and RMB 45 billion, representing a year-over-year growth of 14% to 18% [8]. - Profit forecasts for 2026 to 2028 indicate net profits of RMB 2.47 billion, RMB 4.15 billion, and RMB 5.56 billion, with respective year-over-year growth rates of 73%, 68%, and 34% [8]. Summary by Sections Company Overview - The company operates in the pharmaceutical and biotechnology sector, with a current H-share price of HKD 194.40 and a target price of HKD 229 [2][5]. Financial Performance - In 2025, the company reported total revenue of RMB 38.21 billion, a 40.4% increase year-over-year, with product revenue contributing RMB 37.77 billion [8]. - The net profit for 2025 was RMB 1.42 billion, a significant recovery from a net loss of RMB 4.98 billion in the previous year [8]. Earnings Forecast - The earnings per share (EPS) for 2026 is projected at RMB 2.4, with a price-to-earnings (P/E) ratio of 70 times [7][8]. - The company anticipates maintaining a high gross margin of around 80% in 2026 [8]. Market Position - The major shareholder is Amgen, holding 15.98% of the company [2]. - The stock has shown a year-over-year increase of 35.47% [2].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a potential upside in the stock price [5][6]. Core Insights - The company achieved a revenue growth of 40% in 2025, marking its first year of profitability, with commercial success becoming evident [6][8]. - The primary revenue driver is the self-developed product, Zebutini (BTK inhibitor), which generated global sales of $28.1 billion, reflecting a year-over-year increase of 48.8% [8]. - The company provided guidance for 2026, expecting revenue between RMB 43.6 billion and RMB 45 billion, representing a year-over-year growth of 14% to 18% [8]. - Profit forecasts for 2026 to 2028 are adjusted to RMB 2.47 billion, RMB 4.15 billion, and RMB 5.56 billion, with respective year-over-year growth rates of 73%, 68%, and 34% [8]. Financial Summary - The company reported total revenue of RMB 38.21 billion for 2025, with product revenue contributing RMB 37.77 billion, a year-over-year increase of 39.9% [8]. - The net profit for 2025 was RMB 1.42 billion, a significant recovery from a net loss of RMB 4.98 billion in the previous year [8]. - The earnings per share (EPS) for 2025 is projected at RMB 1.40, with a forecasted increase to RMB 2.43 in 2026 [7][8]. - The company’s market capitalization is approximately RMB 171.82 billion, with a price-to-earnings (P/E) ratio of 121.42 for H shares in 2025 [2][7]. Market Performance - The stock price as of February 26, 2026, was HKD 194.40, with a target price set at HKD 229, indicating a potential upside [2][5]. - The stock has experienced a year-to-date increase of 35.47% [2].

Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside in the stock price [8]. Core Insights - The company achieved a revenue of 1.95 billion RMB in 2025, representing a year-over-year growth of 18.7%. The net profit attributable to the parent company was 270 million RMB, with a year-over-year increase of 9.5% [9]. - In Q4 2025, the company reported a revenue of 600 million RMB, a year-over-year growth of 23.4%, and a net profit of 40 million RMB, reflecting a year-over-year increase of 26.5% [10]. - The company is focusing on the humanoid robot components business, aiming to leverage its product matrix and partnerships to capture growth in this emerging market [10]. - The company is expected to achieve net profits of 270 million RMB, 340 million RMB, and 400 million RMB for the years 2025, 2026, and 2027, respectively, with year-over-year growth rates of 10%, 27%, and 18% [10]. Company Overview - The company operates in the electrical equipment industry, with a current A-share price of 85.52 RMB and a market capitalization of 18.303 billion RMB [2]. - The major shareholder is Nantong Weichuang Electric Technology Co., Ltd., holding 54.12% of the shares [2]. - The company's product portfolio includes 64.1% from inverters, 30.3% from servo systems and control systems, and 3.2% from digital energy [4]. Financial Performance - The company reported a net profit of 191 million RMB in 2023, with a year-over-year increase of 36.38%. The projected net profit for 2024 is 245 million RMB, with a growth rate of 28.42% [11]. - The earnings per share (EPS) for 2025 is projected to be 1.26 RMB, with a year-over-year increase of 8.22% [11]. - The company’s price-to-earnings (P/E) ratio is expected to decrease from 83.84 in 2023 to 45.41 in 2027, indicating a potential increase in valuation [11].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 22 CNY per share [1][6]. Core Insights - The company is expected to benefit significantly from AI technologies, particularly through its Seedance2.0 platform, which enhances the efficiency of animation production and reduces costs [6]. - The company has a strong project pipeline, with anticipated revenues from films like "Flying Life" and "Silent Awakening" contributing significantly to its financial performance [6]. - The "Nezha" IP has become a major asset for the company, with plans for various merchandise and theme park collaborations, indicating a robust strategy for monetizing its intellectual property [6]. Summary by Sections Company Overview - The company operates in the media industry, with a current A-share price of 19.86 CNY and a market capitalization of 55.12 billion CNY [2]. - Major shareholder is Light Media Holdings, owning 37.40% of the company [2]. Recent Ratings - The company has received multiple ratings over the past year, with the most recent being a "Buy" on June 13, 2025, at a closing price of 18.42 CNY [3]. Financial Performance - The company forecasts a net profit of 1.5 to 1.9 billion CNY for 2025, representing a year-on-year growth of 414% to 551% [6]. - Expected net profits for 2025-2027 are projected at 1.77 billion, 1.03 billion, and 1.31 billion CNY, respectively, with corresponding EPS of 0.60, 0.35, and 0.45 CNY [9]. Revenue and Cost Structure - The company anticipates significant revenue growth, with projected revenues of 4.32 billion CNY in 2025, up from 1.55 billion CNY in 2023 [12]. - Operating costs are expected to rise, but the efficiency gains from AI are projected to offset these increases, leading to improved profit margins [6].

2025 年 02 月 27 日 | C0044@capitalcom.tw | | | --- | --- | | 朱吉翔 A 股目标价(人民币) | 1450.0 | 公司基本资讯 | 产业别 | | | 电子 | | --- | --- | --- | --- | | A 股价(2026/2/26) | | | 1168.80 | | 上证指数(2026/2/26) | | | 4146.63 | | 股价 12 个月高/低 | | 1595.88/520.67 | | | 总发行股数(百万) | | | 421.69 | | A 股数(百万) | | | 418.35 | | A 市值(亿元) | | | 4889.68 | | 主要股东 | | 陈天石(28.35%) | | | 每股净值(元) | | | 26.82 | | 股价/账面净值 | | | 43.57 | | 一个月 | | 三个月 | 一年 | | 股价涨跌(%) | -13.7 | -11.3 | 47.9 | 近期评等 C o m p a n y U p d a t e C h i n a R e s e a r c h D e ...

| C0044@capitalcom.tw | | | --- | --- | | 朱吉翔 A 股目标价(人民币) | 1450.0 | 2025 年 02 月 27 日 公司基本资讯 | 产业别 | | | 电子 | | --- | --- | --- | --- | | A 股价(2026/2/26) | | | 1168.80 | | 上证指数(2026/2/26) | | | 4146.63 | | 股价 12 个月高/低 | | 1595.88/520.67 | | | 总发行股数(百万) | | | 421.69 | | A 股数(百万) | | | 418.35 | | A 市值(亿元) | | | 4889.68 | | 主要股东 | | 陈天石(28.35%) | | | 每股净值(元) | | | 26.82 | | 股价/账面净值 | | | 43.57 | | 一个月 | | 三个月 | 一年 | | 股价涨跌(%) | -13.7 | -11.3 | 47.9 | 近期评等 | | | | 产品组合 | | | --- | --- | | 云端智能芯片和加 | 100% | | 速卡 ...

2026 年 02 月 26 日 赵旭东 H70556@capital.com.tw 目标价(元) 10 公司基本信息 | 产业别 | | 轻工制造 | | --- | --- | --- | | A 股价(2026/2/25) | | 8.39 | | 上证指数(2026/2/25) | | 4147.23 | | 股价 12 个月高/低 | | 8.98/3.99 | | 总发行股数(百万) | | 1336.84 | | A 股数(百万) | | 1336.84 | | A 市值(亿元) | | 112.16 | | 主要股东 | | 山东博汇集团有 | | | | 限公司(28.84%) | | 每股净值(元) | | 5.52 | | 股价/账面净值 | | 1.52 | | | 一个月 三个月 | 一年 | | 股价涨跌(%) | 19.3 38.9 | 81.2 | 近期评等 | 出刊日期 | 前日收盘 | 评等 | | --- | --- | --- | | 产品组合 | | | | 白纸板 | | 62.2% | | 文化纸 | | 25.1% | | 箱板纸 | | 6.9% | | 石膏 ...

| 出刊日期 | 前日收盘 | 评等 | | --- | --- | --- | | 产品组合 | | | | 白纸板 | | 62.2% | | 文化纸 | | 25.1% | | 箱板纸 | | 6.9% | | 石膏护面纸 | | 3.0% | 2026 年 02 月 26 日 赵旭东 H70556@capital.com.tw 目标价(元) 10 公司基本信息 | 产业别 | | 轻工制造 | | --- | --- | --- | | A 股价(2026/2/25) | | 8.39 | | 上证指数(2026/2/25) | | 4147.23 | | 股价 12 个月高/低 | | 8.98/3.99 | | 总发行股数(百万) | | 1336.84 | | A 股数(百万) | | 1336.84 | | A 市值(亿元) | | 112.16 | | 主要股东 | | 山东博汇集团有 | | | | 限公司(28.84%) | | 每股净值(元) | | 5.52 | | 股价/账面净值 | | 1.52 | | | 一个月 三个月 | 一年 | | 股价涨跌(%) | 19.3 38.9 ...

Investment Rating - The report assigns a "Trading Buy" rating for the company, indicating a potential upside of 5% to 15% [8][12]. Core Insights - The company is expected to achieve a revenue of RMB 143.76 billion in 2025, representing a year-on-year growth of 56.91%, with a net profit of RMB 25.42 billion, up 31.7% [8]. - For Q1 2026, the company anticipates revenue between RMB 150.98 billion and RMB 181.98 billion, reflecting a growth of 62.91% to 75.82% year-on-year, and a net profit between RMB 114.11 billion and RMB 214.11 billion [8]. - The demand for the company's products is driven by the growth of the global AI industry, with a focus on high-performance, low-power products in the high-end chip market [8]. - The company maintains a strong market position through continuous R&D investment and collaboration with key industry partners [8]. - The termination of a merger will not adversely affect the company's operations or financial status, and it is expected to maintain high gross margins [8]. Financial Summary - The company’s projected net profits for 2025, 2026, and 2027 are RMB 25.42 billion, RMB 44.50 billion, and RMB 68.61 billion, respectively, with year-on-year growth rates of 31.66%, 75.05%, and 54.18% [10][12]. - Earnings per share (EPS) are expected to be RMB 1.09, RMB 1.91, and RMB 2.95 for the same years, with corresponding price-to-earnings (P/E) ratios of 225, 128, and 83 [10][12]. - The company’s revenue is projected to grow from RMB 14.38 billion in 2025 to RMB 32.39 billion by 2027 [14].